MacroGenics PE Ratio 2012-2025 | MGNX
Current and historical p/e ratio for MacroGenics (MGNX) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MacroGenics PE ratio as of August 26, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| MacroGenics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-26 | 1.81 | 0.00 | |
| 2025-06-30 | 1.21 | 0 | 0.00 |
| 2025-03-31 | 1.27 | $-0.89 | 0.00 |
| 2024-12-31 | 3.25 | $-1.08 | 0.00 |
| 2024-09-30 | 3.29 | $-1.58 | 0.00 |
| 2024-06-30 | 4.25 | $-2.20 | 0.00 |
| 2024-03-31 | 14.72 | $-0.39 | 0.00 |
| 2023-12-31 | 9.62 | $-0.16 | 0.00 |
| 2023-09-30 | 4.66 | $0.80 | 5.83 |
| 2023-06-30 | 5.35 | $0.12 | 44.58 |
| 2023-03-31 | 7.17 | $-1.47 | 0.00 |
| 2022-12-31 | 6.71 | $-1.94 | 0.00 |
| 2022-09-30 | 3.46 | $-3.10 | 0.00 |
| 2022-06-30 | 2.95 | $-3.56 | 0.00 |
| 2022-03-31 | 8.81 | $-3.55 | 0.00 |
| 2021-12-31 | 16.05 | $-3.37 | 0.00 |
| 2021-09-30 | 20.94 | $-2.40 | 0.00 |
| 2021-06-30 | 26.86 | $-2.20 | 0.00 |
| 2021-03-31 | 31.85 | $-2.48 | 0.00 |
| 2020-12-31 | 22.86 | $-2.49 | 0.00 |
| 2020-09-30 | 25.19 | $-3.13 | 0.00 |
| 2020-06-30 | 27.92 | $-3.38 | 0.00 |
| 2020-03-31 | 5.82 | $-3.09 | 0.00 |
| 2019-12-31 | 10.88 | $-3.17 | 0.00 |
| 2019-09-30 | 12.76 | $-3.61 | 0.00 |
| 2019-06-30 | 16.97 | $-3.51 | 0.00 |
| 2019-03-31 | 17.98 | $-3.89 | 0.00 |
| 2018-12-31 | 12.70 | $-4.24 | 0.00 |
| 2018-09-30 | 21.44 | $-0.38 | 0.00 |
| 2018-06-30 | 20.65 | $-0.85 | 0.00 |
| 2018-03-31 | 25.16 | $-0.96 | 0.00 |
| 2017-12-31 | 19.00 | $-0.70 | 0.00 |
| 2017-09-30 | 18.48 | $-4.50 | 0.00 |
| 2017-06-30 | 17.51 | $-4.19 | 0.00 |
| 2017-03-31 | 18.60 | $-1.93 | 0.00 |
| 2016-12-31 | 20.44 | $-1.73 | 0.00 |
| 2016-09-30 | 29.91 | $-1.62 | 0.00 |
| 2016-06-30 | 26.99 | $-1.11 | 0.00 |
| 2016-03-31 | 18.75 | $-2.94 | 0.00 |
| 2015-12-31 | 30.97 | $-0.64 | 0.00 |
| 2015-09-30 | 21.42 | $-0.44 | 0.00 |
| 2015-06-30 | 37.97 | $-0.12 | 0.00 |
| 2015-03-31 | 31.37 | $0.15 | 209.13 |
| 2014-12-31 | 35.07 | $-1.39 | 0.00 |
| 2014-09-30 | 20.90 | $-0.84 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.104B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.514B | 26.91 |
| Boston Scientific (BSX) | United States | $155.747B | 37.14 |
| Stryker (SYK) | United States | $149.436B | 30.42 |
| EssilorLuxottica (ESLOY) | France | $144.168B | 0.00 |
| Medtronic (MDT) | Ireland | $117.977B | 16.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.412B | 24.82 |
| ResMed (RMD) | United States | $41.845B | 29.93 |
| GE HealthCare Technologies (GEHC) | United States | $34.055B | 16.01 |
| Agilent Technologies (A) | United States | $33.846B | 22.07 |
| Koninklijke Philips (PHG) | Netherlands | $26.577B | 17.58 |
| Terumo (TRUMY) | Japan | $26.206B | 31.05 |
| Insulet (PODD) | United States | $23.159B | 77.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.260B | 13.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.271B | 0.00 |
| Baxter (BAX) | United States | $12.615B | 9.75 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.048B | 29.56 |
| Lantheus Holdings (LNTH) | United States | $3.819B | 10.32 |
| Envista Holdings (NVST) | United States | $3.510B | 24.56 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.272B | 8.17 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 14.34 |
| ICU Medical (ICUI) | United States | $3.106B | 21.15 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.209B | 47.38 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.005B | 0.00 |
| AtriCure (ATRC) | United States | $1.881B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.877B | 11.82 |
| Green Thumb Industries (GTBIF) | United States | $1.869B | 80.25 |
| Tilray Brands (TLRY) | Canada | $1.530B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.295B | 16.55 |
| AdaptHealth (AHCO) | United States | $1.249B | 17.75 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| InMode (INMD) | Israel | $0.921B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.910B | 0.00 |
| Valneva SE (VALN) | France | $0.802B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.648B | 0.00 |
| SNDL (SNDL) | Canada | $0.631B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.613B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.593B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.505B | 0.00 |
| Evolus (EOLS) | United States | $0.481B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.473B | 16.29 |
| CeriBell (CBLL) | United States | $0.419B | 0.00 |
| Owens & Minor (OMI) | United States | $0.396B | 3.51 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.345B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.08 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.85 |
| TriSalus Life Sciences (TLSI) | United States | $0.246B | 0.00 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.243B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.193B | 16.13 |
| FitLife Brands (FTLF) | United States | $0.171B | 21.05 |
| Biote (BTMD) | United States | $0.160B | 5.30 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.31 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.03 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.92 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.36 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |